XML 49 R40.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2024
Equity [Abstract]  
Stock-Based Compensation Expense The following table presents stock-based compensation expense in the Company’s consolidated statements of comprehensive income:

 

 

 

For the Years Ended December 31,

 

 

 

2024

 

 

2023

 

 

2022

 

 

 

(Amounts in thousands)

 

Cost of product revenue

 

$

1,948

 

 

$

1,933

 

 

$

2,525

 

Research and development

 

 

3,227

 

 

 

2,855

 

 

 

2,622

 

Selling, general and administrative

 

 

42,895

 

 

 

20,787

 

 

 

22,169

 

Total stock-based compensation

 

$

48,070

 

 

$

25,575

 

 

$

27,316

 

Estimated Weighted Average Assumptions

The fair value of stock option awards granted during the years ended December 31, 2024, 2023 and 2022 were calculated using the following estimated assumptions:

 

 

 

For the Years Ended December 31,

 

 

2024

 

2023

 

2022

Expected term (in years)

 

5.09-6.5

 

5.14-6.5

 

5.5-6.5

Expected volatility (range)

 

46.09-48.50%

 

44.78-46.58%

 

41.44-43.96%

Risk-free interest rate

 

3.69-4.48%

 

3.56-4.71%

 

1.86-4.07%

Expected dividend yield

 

0%

 

0%

 

0%

Summary of Option Activity

Information regarding option activity for the year ended December 31, 2024, under the Plans is summarized below:

 

 

 

Shares

 

 

Weighted
average
exercise
price

 

 

Weighted-
Average
Remaining
Contractual
Term
(in Years)

 

 

Aggregate
Intrinsic
Value
(in Thousands)

 

Options outstanding at December 31, 2023

 

 

649,130

 

 

$

85.97

 

 

 

 

 

 

 

Granted

 

 

80,782

 

 

 

173.16

 

 

 

 

 

 

 

Exercised

 

 

(99,679

)

 

 

43.10

 

 

 

 

 

 

 

Forfeited/expired/cancelled(1)

 

 

(34,027

)

 

 

196.49

 

 

 

 

 

 

 

Options outstanding at December 31, 2024

 

 

596,206

 

 

$

98.64

 

 

 

 

 

 

 

Options exercisable at December 31, 2024

 

 

349,744

 

 

$

85.02

 

 

 

 

 

 

 

Vested and expected to vest at December 31, 2024(2)

 

 

590,960

 

 

$

98.05

 

 

 

5.37

 

 

$

35,180

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1)
Includes 13,057 options forfeited pursuant to the 2024 Award Amendment discussed above under “Chief Executive Officer Accounting Modifications.
(2)
Represents the number of vested options as of December 31, 2024 plus the number of unvested options expected to vest as of December 31, 2024, based on the unvested outstanding options at December 31, 2024 adjusted for estimated forfeiture rates of 8% for awards granted to non-executive level employees and 3% for awards granted to executive level employees.
Summary of Restricted Stock Unit Activity Information regarding stock unit activity, which includes activity for restricted stock units and performance stock units, for the year ended December 31, 2024 under the Plans is summarized below:

 

 

 

Shares

 

 

Weighted Average
Grant Date
Fair Value

 

 

Unvested at December 31, 2023

 

 

474,320

 

 

$

155.59

 

 

Awarded

 

 

232,519

 

 

 

177.36

 

 

Vested

 

 

(148,429

)

 

 

148.16

 

 

Forfeited/cancelled(1)

 

 

(87,798

)

 

 

189.71

 

 

Unvested at December 31, 2024

 

 

470,612

 

 

$

162.33

 

 

Vested and expected to vest at December 31, 2024(2)

 

 

412,863

 

 

$

160.77

 

 

 

(1)
Includes 13,146 RSUs and 6,573 PSUs forfeited pursuant to the 2024 Award Amendment discussed above under “Chief Executive Officer Accounting Modifications.
(2)
Represents the number of vested stock units as of December 31, 2024, plus the number of unvested stock units expected to vest as of December 31, 2024, based on the unvested outstanding stock units at December 31, 2024 adjusted for estimated forfeiture rates of 8% for awards granted to non-executive level employees and 3% for awards granted to executive level employees.